Pharmaceutical Preparations · DE · CIK 1840233
Xilio Therapeutics develops masked immuno-oncology therapies activated within tumors to treat cancer effectively and safely
Comparable business profile · signals at a glance
In the 90 days to Mar 26, 2026: 1 insider bought $44K · 2 sold $6K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Shannon James SamuelDirector | Buy | 5,000 | $8.79 | $44K |
| Jan 2, 2026 | Frankenfield Christopher JamesChief Financial Officer | Sell | 7,030 | $0.64 | $4K |
| Jan 2, 2026 | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | Sell | 1,826 | $0.64 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.